237 related articles for article (PubMed ID: 30528780)
1. Value-Based Pricing in Latin America: How Far Away Are We?
Mejía A; Gilardino R; Kristensen FB; Garrison LP;
Value Health Reg Issues; 2018 Dec; 17():219-223. PubMed ID: 30528780
[TBL] [Abstract][Full Text] [Related]
2. Universal coverage with rising healthcare costs; health outcomes research value in decision-making in Latin America.
Augustovski F; García Martí S; Pichon Riviere A; Rubinstein A
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):657-9. PubMed ID: 22098279
[TBL] [Abstract][Full Text] [Related]
3. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
[TBL] [Abstract][Full Text] [Related]
4. High cost drugs in Latin America: access and barriers.
Rosselli D
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(6):619-623. PubMed ID: 37185151
[TBL] [Abstract][Full Text] [Related]
5. Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences.
Augustovski F; Alcaraz A; Caporale J; García Martí S; Pichon Riviere A
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):9-12. PubMed ID: 25420744
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts.
Hu J; Mossialos E
Health Policy; 2016 May; 120(5):519-34. PubMed ID: 27080345
[TBL] [Abstract][Full Text] [Related]
7. HEALTH TECHNOLOGY ASSESSMENT FOR DECISION MAKING IN LATIN AMERICA: GOOD PRACTICE PRINCIPLES.
Pichon-Riviere A; Soto NC; Augustovski FA; García Martí S; Sampietro-Colom L
Int J Technol Assess Health Care; 2018 Jan; 34(3):241-247. PubMed ID: 29888696
[TBL] [Abstract][Full Text] [Related]
8. Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America.
Gilardino RE; Mejía A; Guarín D; Rey-Ares L; Perez A
Value Health Reg Issues; 2020 Dec; 23():6-12. PubMed ID: 31999988
[TBL] [Abstract][Full Text] [Related]
9. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
Vogler S; Paris V; Ferrario A; Wirtz VJ; de Joncheere K; Schneider P; Pedersen HB; Dedet G; Babar ZU
Appl Health Econ Health Policy; 2017 Jun; 15(3):307-321. PubMed ID: 28063134
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016: brief update.
Augustovski F; Caro J; Ferraz MB; Zárate V
Value Health Reg Issues; 2016 Dec; 11():74-75. PubMed ID: 27986202
[No Abstract] [Full Text] [Related]
11. The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare.
Critchley GJ; Zaric GS
Health Econ; 2019 Aug; 28(8):1035-1051. PubMed ID: 31310424
[TBL] [Abstract][Full Text] [Related]
12.
Leopold C; Poblete S; Vogler S
J Law Med Ethics; 2023; 51(S1):76-91. PubMed ID: 38156346
[TBL] [Abstract][Full Text] [Related]
13. Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?
Tanvejsilp P; Taychakhoonavudh S; Chaikledkaew U; Chaiyakunapruk N; Ngorsuraches S
Value Health Reg Issues; 2019 May; 18():78-82. PubMed ID: 30641410
[TBL] [Abstract][Full Text] [Related]
14. HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status.
Rosselli D; Quirland-Lazo C; Csanádi M; Ruiz de Castilla EM; González NC; Valdés J; Abicalaffe C; Garzón W; Leon G; Kaló Z
Value Health Reg Issues; 2017 Dec; 14():20-27. PubMed ID: 29254537
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation guidelines in Latin America: a current snapshot.
Augustovski F; Garay OU; Pichon-Riviere A; Rubinstein A; Caporale JE
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):525-37. PubMed ID: 20950069
[TBL] [Abstract][Full Text] [Related]
16. Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America.
Pichon-Riviere A; Augustovski F; García Martí S; Alcaraz A; Alfie V; Sampietro-Colom L
Int J Technol Assess Health Care; 2021 Aug; 37(1):e80. PubMed ID: 34392842
[TBL] [Abstract][Full Text] [Related]
17. Realizing the right to health in Latin America, equitably.
Villar Uribe M; Escobar ML; Ruano AL; Iunes RF
Int J Equity Health; 2021 Jan; 20(1):34. PubMed ID: 33441143
[TBL] [Abstract][Full Text] [Related]
18. Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.
Pichon-Riviere A; Garcia-Marti S; Oortwijn W; Augustovski F; Sampietro-Colom L
Int J Technol Assess Health Care; 2019 Jan; 35(1):64-68. PubMed ID: 30938278
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Health Technology Assessment in Latin America and the Caribbean: Keeping the Region on Course.
Giedion U; Espinoza MA; Góngora-Salazar P; Mehndiratta A; Ollendorff D
Health Syst Reform; 2023 Dec; 9(3):2314482. PubMed ID: 38715203
[TBL] [Abstract][Full Text] [Related]
20. STATUS OF DISINVESTMENT INITIATIVES IN LATIN AMERICA: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW AND A QUESTIONNAIRE.
Agirrezabal I; Burgon J; Stewart G; Gutierrez-Ibarluzea I
Int J Technol Assess Health Care; 2017 Jan; 33(6):674-680. PubMed ID: 28956521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
